AbdullahKhanMD
Hematology • Columbus, OHHematologic Oncology
Assistant Professor, Division Of Hematology
Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-4812
Education & Training
Aga Khan Medical CollegeClass of 2010
University of FloridaFellowship, Hematology and Medical Oncology
Hackensack University Medical CenterResidency, Internal Medicine
Certifications & Licensure
NY State Medical License 2011 - 2026
OH State Medical License 2018 - 2026
FL State Medical License 2015 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma Start of enrollment: 2021 Sep 27
- Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies Start of enrollment: 2023 Dec 21
Roles: Sponsor-Investigator, Contact, Principal Investigator
Publications & Presentations
PubMed
- 2 citationsCellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review.Nina Rosa Neuendorff, Abdullah Khan, Fabian Ullrich, Samuel Yates, Srinivas Devarakonda
Journal of Geriatric Oncology. 2024-04-01 - Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents.Muhammad Salman Faisal, Walter Hanel, Timothy Voorhees, Rui Li, Ying Huang
Cancer Medicine. 2023-04-01 - 2 citationsOutcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience.Abdullah M Khan, Michael Ozga, Harshil Bhatt, Muhammad S Faisal, Sadia Ansari
Clinical Lymphoma, Myeloma & Leukemia. 2023-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
